Clincosm LogoSign in Get a demo

Examining the Usage of Dopamine Blockers in OCD Patients

Sponsor
Sheba Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT00496925
Collaborator
(none)
63
Enrollment
1
Location
20
Duration (Months)
3.2
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

We examine the usage of Dopamine blockers in OCD patients. We want to examine their frequency of usage, compare the course of the disease between those who receive and those who do not receive Dopamine blockers, and efficacy of the treatment.

The study will be done in two stages: 1. Collecting information the usage of Dopamine blockers from 150 OCD patients' files. 2. interviewing 60-70 patients to see the difference those who receive and those who do not receive Dopamine blockers in their current severity of disease.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    63 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Examining the Usage of Dopamine Blockers in OCD Patients
    Study Start Date :
    Nov 1, 2007
    Actual Primary Completion Date :
    Jul 1, 2009
    Actual Study Completion Date :
    Jul 1, 2009

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:

      • Patients over 18 years of age

      • DSM-IV diagnosis of OCD

      • Ability to understand patient information sheet, and consent to participate

      Exclusion Criteria:
      • Current or past Psychotic or Bipolar disorder

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Chaim Sheba Medical Center Ramat-Gan Israel 52621

      Sponsors and Collaborators

      • Sheba Medical Center

      Investigators

      • Principal Investigator: Joseph Zohar, MD, Chaim Sheba Medical Center

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00496925
      Other Study ID Numbers:
      • SHEBA- 07-4651-JZ-CTIL
      First Posted:
      Jul 6, 2007
      Last Update Posted:
      Feb 2, 2010
      Last Verified:
      Jan 1, 2010
      Additional relevant MeSH terms:
      Obsessive-Compulsive Disorder

      Study Results

      No Results Posted as of Feb 2, 2010